TotalMarketCap

Matinas BioPharma

MTNBNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.097 M

$1.12 -5.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Matinas BioPharma (MTNB) has a market capitalization of $1.10M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$10.3M

Loss-making

Shares outstanding

14,692,796

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #494Biodexa PharmaceuticalsBDRX$1.26M
  2. #495Artelo BiosciencesARTL$1.16M
  3. #496Matinas BioPharmaMTNB$1.10M
  4. #497CDT EquityCDT$881.5K
  5. #498SciSparcSPRC$869.4K

What if Matinas BioPharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$28,827,267

Per share 25,738,631× higher

Bitcoin $1.53T

$1,559,793

Per share 1,392,672× higher

Apple $5.02T

$5,120,655

Per share 4,572,014× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Matinas BioPharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.